Aphria (
T.APHA) is reporting its subsidiary in Malta has awarded a key European Union certification, allowing the Ontario-based cannabis producer to begin shipping medical cannabis to the continent.
The company’s Avanti Rx Analytics subsidiary received the Good Manufacturing Practices certification from Maltese authorities, and expects the first shipments of medical cannabis to its German pharmaceutical business will occur in its fourth quarter of its fiscal 2020.
According to regulatory documents published online, the company’s Aphria One facility in Leamington, ON also appears to have been awarded the EU-GMP certification.
Full press release
here.
Aphria (
T.APHA) is reporting its Maltese subsidiary has awarded a key European Union certification, allowing the Ontario-based cannabis producer to begin shipping medical cannabis to the continent.
The company’s Avanti Rx Analytics subsidiary received the Good Manufacturing Practices certification from Maltese authorities, and expects the first shipments of medical cannabis to its German pharmaceutical business will occur in its fourth quarter of its fiscal 2020.
According to regulatory documents published online, the company’s Aphria One facility in Leamington, ON also appears to have been awarded the EU-GMP certification.
Full press release
here.